At the recent DIA Annual Meeting the top subject, or so it appeared, on everyone’s minds was safety. Adverse event reporting, pharmacovigilance, etc were buzzwords that one didn’t have to look far to hear.
If someone asked you, as a life scientist, what the top priorities in healthcare should be, what would you say? In my opinion, we need to be thinking seriously about how we can change drug development paradigms in the context of all the information that we have to try and make sure that attrition rates are decreased dramatically. Current efforts are just extensions of what we’ve been doing for years, and they are not working. Safety would be right up there, along with trying to rebuild public trust.
Technorati Tags: Healthcare, Adverse Events, DIA, Drug Development
One Trackback
[...] Further reading: Safety the number one concern Pharmacovigilance and adverse events The life science hype cycle Reality lies somewhere between hype and the naysayers [...]